Figure 2.

Estimated per-patient costs by vtDR subtype during year one and years two to five. A, with or B, without medication costs included. Shown are adverse events costs (purple), clinic visit costs (orange), cost of pan-retinal photocoagulation (gray), cost of focal laser therapy (yellow), intravitreous injection procedure costs (light blue), and medication costs for 0.5-mg ranibizumab (green).